Shots:
- The FDA has approved Patient-Specific Talus Spacer 3D-printed talus implant for humanitarian use. The FDA reviewed data through the HDE process
- Data supporting the safety of implant include results from 31 patients and 32 talus replacement surgeries with the implant. Post-operation @3yrs, pain decreased from “mod. to sev.” prior to surgery to “mild” post-surgery, and range of motion in the ankle joint is also improved
- The implant is the first of its kind to replace the talus for the treatment of AVN of ankle joint. The implant provides a joint-sparing alternative to other surgical interventions used in late-stage AVN that may disable motion of the ankle joint
Click here to read full press release/ article | Ref: FDA | Image: Crunchbase
The post The US FDA Approves Patient Specific Talus Spacer to Treat AVN of Ankle Joint as a Humanitarian Use Device first appeared on PharmaShots.
